Home
Live Updates
Agomab Therapeutics NV: Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114 Million : comparemela.com
Agomab Therapeutics NV: Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114 Million
-- Extension led by Pfizer with participation from new investors Walleye Capital and Asabys Partners as well as existing investors -- -- Funding will support next stage of clinical and corporate development
Related Keywords
Kostenloser Wertpapierhandel ,
Laura Mittmann ,
Tim Knotnerus ,
Thomas Wynn ,
Michael Vincent ,
Pfizer ,
Redmile Group ,
Trophic Communications ,
Pfizer Breakthrough Growth Initiative ,
Walleye Capital ,
Asabys Partners ,
Vice President ,
Inflammation Immunology Discovery Biology ,
Scientific Advisory ,
Chief Executive Officer ,
Origo Biopharma ,
Senior Vice President ,
Chief Scientific Officer ,
Inflammation Immunology ,
Agomab Therapeutics ,
Agomab ,
Herapeutics ,
Raises ,
Dditional ,
Billion ,
Through ,
Series ,
Extension ,
Ringing ,
Total ,
Amount ,
comparemela.com © 2020. All Rights Reserved.